nodes	percent_of_prediction	percent_of_DWPC	metapath
Pitavastatin—ALB—Scavenging of heme from plasma—AMBP—nephrolithiasis	0.043	0.0798	CbGpPWpGaD
Pitavastatin—CYP2C9—urine—nephrolithiasis	0.0223	0.0957	CbGeAlD
Pitavastatin—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.021	0.0919	CcSEcCtD
Pitavastatin—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.0186	0.0815	CcSEcCtD
Pitavastatin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—AMBP—nephrolithiasis	0.0172	0.0318	CbGpPWpGaD
Pitavastatin—SLC10A1—renal system—nephrolithiasis	0.0163	0.07	CbGeAlD
Pitavastatin—SLC10A1—kidney—nephrolithiasis	0.0157	0.0676	CbGeAlD
Pitavastatin—UGT2B7—renal system—nephrolithiasis	0.0152	0.0655	CbGeAlD
Pitavastatin—UGT2B7—kidney—nephrolithiasis	0.0147	0.0634	CbGeAlD
Pitavastatin—UGT1A3—Phase II conjugation—SLC26A1—nephrolithiasis	0.0126	0.0233	CbGpPWpGaD
Pitavastatin—HMGCR—nephron tubule—nephrolithiasis	0.0124	0.0533	CbGeAlD
Pitavastatin—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.012	0.0524	CcSEcCtD
Pitavastatin—ABCG2—Iron uptake and transport—ATP6V0A4—nephrolithiasis	0.0117	0.0216	CbGpPWpGaD
Pitavastatin—HMGCR—renal system—nephrolithiasis	0.0113	0.0484	CbGeAlD
Pitavastatin—HMGCR—kidney—nephrolithiasis	0.0109	0.0468	CbGeAlD
Pitavastatin—SLCO1B1—renal system—nephrolithiasis	0.0108	0.0464	CbGeAlD
Pitavastatin—UGT2B7—Phase II conjugation—SLC26A1—nephrolithiasis	0.0107	0.0198	CbGpPWpGaD
Pitavastatin—HMGCR—cortex of kidney—nephrolithiasis	0.0106	0.0456	CbGeAlD
Pitavastatin—SLCO1B1—kidney—nephrolithiasis	0.0104	0.0448	CbGeAlD
Pitavastatin—Influenza—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0453	CcSEcCtD
Pitavastatin—SLCO2B1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0099	0.0184	CbGpPWpGaD
Pitavastatin—SLCO2B1—renal system—nephrolithiasis	0.00954	0.041	CbGeAlD
Pitavastatin—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00952	0.0417	CcSEcCtD
Pitavastatin—SLCO2B1—kidney—nephrolithiasis	0.00922	0.0396	CbGeAlD
Pitavastatin—SLCO2B1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00905	0.0168	CbGpPWpGaD
Pitavastatin—SLCO2B1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00905	0.0168	CbGpPWpGaD
Pitavastatin—ABCC2—nephron tubule—nephrolithiasis	0.009	0.0387	CbGeAlD
Pitavastatin—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00898	0.0393	CcSEcCtD
Pitavastatin—UGT1A3—NRF2 pathway—SLC2A9—nephrolithiasis	0.00839	0.0156	CbGpPWpGaD
Pitavastatin—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00827	0.0362	CcSEcCtD
Pitavastatin—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00823	0.0361	CcSEcCtD
Pitavastatin—ABCC2—renal system—nephrolithiasis	0.00818	0.0352	CbGeAlD
Pitavastatin—ABCC2—kidney—nephrolithiasis	0.00791	0.034	CbGeAlD
Pitavastatin—SLCO1B3—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00773	0.0143	CbGpPWpGaD
Pitavastatin—ABCC2—cortex of kidney—nephrolithiasis	0.0077	0.0331	CbGeAlD
Pitavastatin—UGT1A3—Biological oxidations—SLC26A1—nephrolithiasis	0.00736	0.0136	CbGpPWpGaD
Pitavastatin—UGT2B7—NRF2 pathway—SLC2A9—nephrolithiasis	0.00713	0.0132	CbGpPWpGaD
Pitavastatin—SLCO1B3—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00707	0.0131	CbGpPWpGaD
Pitavastatin—SLCO1B3—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00707	0.0131	CbGpPWpGaD
Pitavastatin—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00697	0.0305	CcSEcCtD
Pitavastatin—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00692	0.0303	CcSEcCtD
Pitavastatin—SLCO2B1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00686	0.0127	CbGpPWpGaD
Pitavastatin—SLCO2B1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00686	0.0127	CbGpPWpGaD
Pitavastatin—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00668	0.0293	CcSEcCtD
Pitavastatin—ABCG2—nephron tubule—nephrolithiasis	0.00656	0.0282	CbGeAlD
Pitavastatin—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00649	0.0284	CcSEcCtD
Pitavastatin—SLCO2B1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00638	0.0118	CbGpPWpGaD
Pitavastatin—SLCO2B1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00638	0.0118	CbGpPWpGaD
Pitavastatin—UGT2B7—Biological oxidations—SLC26A1—nephrolithiasis	0.00626	0.0116	CbGpPWpGaD
Pitavastatin—CYP2C8—renal system—nephrolithiasis	0.00613	0.0264	CbGeAlD
Pitavastatin—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00613	0.0269	CcSEcCtD
Pitavastatin—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00613	0.0269	CcSEcCtD
Pitavastatin—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00606	0.0265	CcSEcCtD
Pitavastatin—CYP2C8—kidney—nephrolithiasis	0.00593	0.0255	CbGeAlD
Pitavastatin—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00593	0.026	CcSEcCtD
Pitavastatin—SLCO2B1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00569	0.0105	CbGpPWpGaD
Pitavastatin—ABCC2—NRF2 pathway—SLC2A9—nephrolithiasis	0.00565	0.0105	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00564	0.0105	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00564	0.0105	CbGpPWpGaD
Pitavastatin—SLCO1B3—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00536	0.00994	CbGpPWpGaD
Pitavastatin—SLCO1B3—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00536	0.00994	CbGpPWpGaD
Pitavastatin—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00535	0.0235	CcSEcCtD
Pitavastatin—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00532	0.0233	CcSEcCtD
Pitavastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00519	0.00963	CbGpPWpGaD
Pitavastatin—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00517	0.0227	CcSEcCtD
Pitavastatin—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00507	0.0222	CcSEcCtD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00503	0.00933	CbGpPWpGaD
Pitavastatin—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00503	0.022	CcSEcCtD
Pitavastatin—SLCO1B3—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00498	0.00924	CbGpPWpGaD
Pitavastatin—SLCO1B3—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00498	0.00924	CbGpPWpGaD
Pitavastatin—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00484	0.0212	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00481	0.0211	CcSEcCtD
Pitavastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00475	0.00881	CbGpPWpGaD
Pitavastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00475	0.00881	CbGpPWpGaD
Pitavastatin—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00467	0.0205	CcSEcCtD
Pitavastatin—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00465	0.0204	CcSEcCtD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.0046	0.00854	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.0046	0.00854	CbGpPWpGaD
Pitavastatin—SLCO1B3—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00444	0.00824	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00441	0.00818	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00441	0.00818	CbGpPWpGaD
Pitavastatin—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00433	0.019	CcSEcCtD
Pitavastatin—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00422	0.0185	CcSEcCtD
Pitavastatin—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00416	0.0182	CcSEcCtD
Pitavastatin—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00402	0.0176	CcSEcCtD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00393	0.00729	CbGpPWpGaD
Pitavastatin—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00389	0.017	CcSEcCtD
Pitavastatin—Rash—Hydrochlorothiazide—nephrolithiasis	0.00371	0.0162	CcSEcCtD
Pitavastatin—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.0037	0.0162	CcSEcCtD
Pitavastatin—Headache—Hydrochlorothiazide—nephrolithiasis	0.00368	0.0161	CcSEcCtD
Pitavastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.0036	0.00668	CbGpPWpGaD
Pitavastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.0036	0.00668	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00359	0.00666	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00359	0.00666	CbGpPWpGaD
Pitavastatin—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00349	0.0153	CcSEcCtD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00349	0.00647	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00349	0.00647	CbGpPWpGaD
Pitavastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00335	0.00621	CbGpPWpGaD
Pitavastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00335	0.00621	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00324	0.00601	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00324	0.00601	CbGpPWpGaD
Pitavastatin—ABCB1—nephron tubule—nephrolithiasis	0.00324	0.0139	CbGeAlD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00315	0.00585	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00315	0.00585	CbGpPWpGaD
Pitavastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00298	0.00553	CbGpPWpGaD
Pitavastatin—ALB—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00297	0.0055	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00296	0.00549	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00296	0.00549	CbGpPWpGaD
Pitavastatin—ABCB1—renal system—nephrolithiasis	0.00294	0.0126	CbGeAlD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00289	0.00536	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00289	0.00536	CbGpPWpGaD
Pitavastatin—ABCB1—kidney—nephrolithiasis	0.00284	0.0122	CbGeAlD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00281	0.00521	CbGpPWpGaD
Pitavastatin—ABCB1—cortex of kidney—nephrolithiasis	0.00277	0.0119	CbGeAlD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00274	0.00509	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00274	0.00509	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00272	0.00505	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00272	0.00505	CbGpPWpGaD
Pitavastatin—ALB—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00271	0.00503	CbGpPWpGaD
Pitavastatin—ALB—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00271	0.00503	CbGpPWpGaD
Pitavastatin—CYP2C8—Biological oxidations—SLC26A1—nephrolithiasis	0.00268	0.00497	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00264	0.0049	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00257	0.00477	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00257	0.00477	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00253	0.0047	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00253	0.0047	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—GRHPR—nephrolithiasis	0.0025	0.00463	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00244	0.00453	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00241	0.00448	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00241	0.00448	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00231	0.00428	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00226	0.00419	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00226	0.00419	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00224	0.00415	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00224	0.00415	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—AGXT—nephrolithiasis	0.00223	0.00413	CbGpPWpGaD
Pitavastatin—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.00218	0.00404	CbGpPWpGaD
Pitavastatin—ALB—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00206	0.00382	CbGpPWpGaD
Pitavastatin—ALB—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00206	0.00382	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—GRHPR—nephrolithiasis	0.00204	0.00378	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00195	0.00361	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00195	0.00361	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00194	0.0036	CbGpPWpGaD
Pitavastatin—ALB—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00191	0.00355	CbGpPWpGaD
Pitavastatin—ALB—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00191	0.00355	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—APRT—nephrolithiasis	0.00189	0.00351	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—SLC26A1—nephrolithiasis	0.00189	0.00351	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00183	0.00339	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00183	0.00339	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—AGXT—nephrolithiasis	0.00182	0.00337	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00181	0.00336	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00181	0.00336	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.0018	0.00335	CbGpPWpGaD
Pitavastatin—ALB—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.0017	0.00316	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.0017	0.00315	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.0017	0.00315	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00169	0.00314	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00169	0.00314	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00169	0.00314	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00169	0.00314	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—GRHPR—nephrolithiasis	0.00166	0.00308	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00161	0.00299	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00161	0.00299	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00157	0.00292	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00157	0.00292	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—GRHPR—nephrolithiasis	0.00156	0.0029	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—APRT—nephrolithiasis	0.00154	0.00286	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—SLC26A1—nephrolithiasis	0.00154	0.00286	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00152	0.00281	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00152	0.00281	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00151	0.0028	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00148	0.00275	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00148	0.00275	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—AGXT—nephrolithiasis	0.00148	0.00274	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—GRHPR—nephrolithiasis	0.00141	0.00262	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.0014	0.0026	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.0014	0.0026	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—AGXT—nephrolithiasis	0.00139	0.00259	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00138	0.00256	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00138	0.00256	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—AQP1—nephrolithiasis	0.00135	0.0025	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00132	0.00245	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00129	0.00239	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—SLC26A1—nephrolithiasis	0.00126	0.00233	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—APRT—nephrolithiasis	0.00126	0.00233	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—AGXT—nephrolithiasis	0.00126	0.00233	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—CHRM3—nephrolithiasis	0.00122	0.00226	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00121	0.00225	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00121	0.00224	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00121	0.00224	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—APRT—nephrolithiasis	0.00119	0.0022	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—SLC26A1—nephrolithiasis	0.00119	0.0022	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00112	0.00208	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—AQP1—nephrolithiasis	0.0011	0.00204	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—SLC26A1—nephrolithiasis	0.00107	0.00198	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—APRT—nephrolithiasis	0.00107	0.00198	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GRHPR—nephrolithiasis	0.00105	0.00195	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00105	0.00194	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00105	0.00194	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—DGKH—nephrolithiasis	0.001	0.00186	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—SLC7A9—nephrolithiasis	0.001	0.00186	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—CHRM3—nephrolithiasis	0.000995	0.00184	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GRHPR—nephrolithiasis	0.000973	0.00181	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000972	0.0018	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000972	0.0018	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—AGXT—nephrolithiasis	0.000937	0.00174	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000916	0.0017	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000916	0.0017	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—AQP1—nephrolithiasis	0.000896	0.00166	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—AGXT—nephrolithiasis	0.000867	0.00161	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000866	0.00161	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000866	0.00161	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000851	0.00158	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000851	0.00158	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—AQP1—nephrolithiasis	0.000845	0.00157	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—CHRM3—nephrolithiasis	0.000811	0.0015	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—SLC26A1—nephrolithiasis	0.000797	0.00148	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—APRT—nephrolithiasis	0.000797	0.00148	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—CHRM3—nephrolithiasis	0.000764	0.00142	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—AQP1—nephrolithiasis	0.000762	0.00141	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000759	0.00141	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000759	0.00141	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—SLC26A1—nephrolithiasis	0.000738	0.00137	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—APRT—nephrolithiasis	0.000738	0.00137	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000692	0.00128	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—CHRM3—nephrolithiasis	0.000689	0.00128	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000607	0.00113	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GRHPR—nephrolithiasis	0.000604	0.00112	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GRHPR—nephrolithiasis	0.000601	0.00111	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—AQP1—nephrolithiasis	0.000568	0.00105	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—AGXT—nephrolithiasis	0.000538	0.000999	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—AGXT—nephrolithiasis	0.000535	0.000993	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000526	0.000976	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—AQP1—nephrolithiasis	0.000526	0.000975	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CHRM3—nephrolithiasis	0.000513	0.000952	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.000492	0.000912	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CHRM3—nephrolithiasis	0.000475	0.000882	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000469	0.00087	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—APRT—nephrolithiasis	0.000458	0.000849	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—SLC26A1—nephrolithiasis	0.000458	0.000849	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—SLC26A1—nephrolithiasis	0.000455	0.000844	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—APRT—nephrolithiasis	0.000455	0.000844	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.000438	0.000813	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000399	0.00074	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—APRT—nephrolithiasis	0.000399	0.00074	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	0.000373	0.000691	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—APRT—nephrolithiasis	0.000373	0.000691	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—AQP1—nephrolithiasis	0.000326	0.000605	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—AQP1—nephrolithiasis	0.000324	0.000602	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CHRM3—nephrolithiasis	0.000295	0.000547	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CHRM3—nephrolithiasis	0.000293	0.000544	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—AQP1—nephrolithiasis	0.000284	0.000527	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—AQP1—nephrolithiasis	0.000265	0.000492	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CHRM3—nephrolithiasis	0.000257	0.000477	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CHRM3—nephrolithiasis	0.00024	0.000445	CbGpPWpGaD
